Edition:
United States

Respiri Ltd (RSH.AX)

RSH.AX on Australia Stock Exchange

0.03AUD
17 Aug 2017
Change (% chg)

-- (--)
Prev Close
$0.03
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
471,298
52-wk High
$0.07
52-wk Low
$0.03

Summary

Name Age Since Current Position

Leon L'Huillier

2014 Chairman of the Board

David Model

2011 Senior Vice President - Finance

Jenni Lightowlers

2017 Company Secretary

Timothy Oldham

2014 Non-Executive Director

John Ribot-de-Bresac

2014 Non-Executive Director

Biographies

Name Description

Leon L'Huillier

Mr. Leon Michael L'Huillier is Chairman of the Board of Isonea Ltd effective February 4, 2014. Leon is an experienced chairman and company director with a background in health, retail and consumer goods and private equity. Leon is a former director of Woolworths and chairman of its audit and risk management committee. Currently he is a deputy chairman of Australian Prostate Cancer Research, a former chairman of the Australian Health Ministers Advisory Council, The Royal Children’s Hospital Brisbane and a former director of St. Vincent’s Hospital Melbourne and The Bernard O’Brien Institute of Microsurgery. He has also been a director of private equity in association with Archer Capital, Gresham, and Macquarie Bank.

David Model

Jenni Lightowlers

Timothy Oldham

Dr. Timothy (Tim) Charles Oldham is Non-Executive Director of Isonea Ltd effective January 6, 2014. Dr. Oldham has more than a decade of direct life sciences business development, alliance management, market entry, and sales & marketing experience in Europe, Asia and Australia including as President of Asia Pacific for Hospira, Inc. (2007 to 2012), and a variety of senior management roles with Mayne Pharma (2002 to 2007) prior to its acquisition by Hospira. These roles encompassed the development and commercialisation of pharmaceuticals, devices and biologics. Prior to this, he was an engagement manager with McKinsey & Co (1997 to 2001). Dr. Oldham has been chairman of the European Generic Medicines Association Biosimilars and Biotechnology Committee, a director of the Generic Medicines Industry Association and a member of the Pharmaceutical Industry Strategy Group. He is a also a Director of Acrux Ltd (ASX:ACR).

John Ribot-de-Bresac

Mr. John Ribot-de-Bresac is Non-Executive Director of Isonea Ltd effective February 4, 2014. He has experience and a record of achievement as a senior executive across the sport, leisure and hospitality industries including in strategy development and implementation. Following a distinguished sports career where he received the Australian Sports Medal, he was involved in the establishment of the Brisbane Broncos and Melbourne Storm, in executive director roles, and as chairman of the Brisbane Roar. Currently John serves as director of Victorian Major Events Company, executive chairman of Queensland Clubs Management (QCM), and owns hospitality venues throughout Queensland.

Basic Compensation

Name Fiscal Year Total

Leon L'Huillier

--

David Model

133,354

Jenni Lightowlers

--

Timothy Oldham

--

John Ribot-de-Bresac

--
As Of  29 Jun 2013

Options Compensation